Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Singular Health Group Ltd ( (AU:SHG) ) has shared an update.
Singular Health Group reported a quarter of consolidation and expansion, advancing commercial deployments and education partnerships, particularly in the U.S. healthcare and academic markets. The company aims to deliver scalable, interoperable imaging solutions across clinical, educational and enterprise environments, supported by recent regulatory progress.
The group expanded its agreement with Provider Network Solutions by deploying an additional 500 3DICOM MD licences, receiving a US$500,000 licensing payment and recording early success in reducing duplicate imaging costs, which is supporting discussions on expansion and renewal of the deal. Singular Health also completed a full go-live of 3DICOM Patient at Life Radiology’s Miami clinic, executed an agreement with Miami-Dade County Public Schools to roll out 3DICOM EDU, signed an MoU with Florida International University, and secured FDA 510(k) clearance for its cloud platform, strengthening its U.S. market positioning and regulatory credentials.
More about Singular Health Group Ltd
Singular Health Group Ltd, listed on the ASX, operates in the medical imaging and health technology sector, providing 3D visualisation and cloud-based imaging software. Its primary products include 3DICOM MD for clinicians, 3DICOM Patient for radiology image delivery, and 3DICOM EDU for education, with a growing focus on the U.S. healthcare and education markets.
Average Trading Volume: 399,623
Technical Sentiment Signal: Sell
Current Market Cap: A$69.51M
Learn more about SHG stock on TipRanks’ Stock Analysis page.